Jeff Wagener, M.D.

Affiliations: 
Pediatrics University of Colorado, Boulder, Boulder, CO, United States 
Google:
"Jeff Wagener"

Parents

Sign in to add mentor
Lynn Taussig fellowship/program director 1978-1981 University of Arizona

Children

Sign in to add trainee
Terri A. Laguna fellowship/program director CU Boulder
Deborah R. Liptzin fellowship/program director 2012-2015
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wagener JS, Williams MJ, Millar SJ, et al. (2018) Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
McKone E, Sawicki G, Millar S, et al. (2016) ePS03.4 Improved rate of decline in percent predicted FEV 1 (ppFEV 1 ) is not associated with acute improvement in ppFEV 1 in patients with cystic fibrosis (CF) treated with ivacaftor Journal of Cystic Fibrosis. 15: S42
Rubin-Cahill J, Thayer S, Watkins A, et al. (2015) 191 Lung function and health care resource utilization in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S107
Rubin-Cahill J, Thayer S, Watkins A, et al. (2015) 190 Frequency and costs of pulmonary exacerbations and association with % predicted FEV 1 in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S106
Sawicki G, McKone E, Pasta D, et al. (2014) WS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation Journal of Cystic Fibrosis. 13: S6
Sagel SD, Gibson RL, Emerson J, et al. (2009) Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. The Journal of Pediatrics. 154: 183-8
See more...